↓ Skip to main content

The Role of the Insulin/IGF System in Cancer: Lessons Learned from Clinical Trials and the Energy Balance-Cancer Link

Overview of attention for article published in Frontiers in endocrinology, May 2015
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (91st percentile)
  • High Attention Score compared to outputs of the same age and source (92nd percentile)

Mentioned by

news
2 news outlets
twitter
2 X users
facebook
1 Facebook page
wikipedia
2 Wikipedia pages
video
2 YouTube creators

Citations

dimensions_citation
120 Dimensions

Readers on

mendeley
137 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
The Role of the Insulin/IGF System in Cancer: Lessons Learned from Clinical Trials and the Energy Balance-Cancer Link
Published in
Frontiers in endocrinology, May 2015
DOI 10.3389/fendo.2015.00077
Pubmed ID
Authors

Laura W. Bowers, Emily L. Rossi, Ciara H. O’Flanagan, Linda A. deGraffenried, Stephen D. Hursting

Abstract

Numerous epidemiological and pre-clinical studies have demonstrated that the insulin/insulin-like growth factor (IGF) system plays a key role in the development and progression of several types of cancer. Insulin/IGF signaling, in cooperation with chronic low-grade inflammation, is also an important contributor to the cancer-promoting effects of obesity. However, clinical trials for drugs targeting different components of this system have produced largely disappointing results, possibly due to the lack of predictive biomarker use and problems with the design of combination therapy regimens. With careful attention to the identification of likely patient responders and optimal drug combinations, the outcome of future trials may be improved. Given that insulin/IGF signaling is known to contribute to obesity-associated cancer, further investigation regarding the efficacy of drugs targeting this system and its downstream effectors in the obese patient population is warranted.

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 137 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Belgium 1 <1%
Brazil 1 <1%
Unknown 135 99%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 23 17%
Student > Master 23 17%
Researcher 15 11%
Student > Postgraduate 14 10%
Student > Bachelor 13 9%
Other 24 18%
Unknown 25 18%
Readers by discipline Count As %
Medicine and Dentistry 40 29%
Biochemistry, Genetics and Molecular Biology 27 20%
Nursing and Health Professions 15 11%
Agricultural and Biological Sciences 12 9%
Neuroscience 4 3%
Other 10 7%
Unknown 29 21%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 18. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 October 2023.
All research outputs
#2,007,336
of 25,628,260 outputs
Outputs from Frontiers in endocrinology
#520
of 13,257 outputs
Outputs of similar age
#24,850
of 279,946 outputs
Outputs of similar age from Frontiers in endocrinology
#5
of 53 outputs
Altmetric has tracked 25,628,260 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 92nd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,257 research outputs from this source. They receive a mean Attention Score of 5.0. This one has done particularly well, scoring higher than 96% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 279,946 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 91% of its contemporaries.
We're also able to compare this research output to 53 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 92% of its contemporaries.